Molecular analysis of Evi1, a zinc finger oncogene involved in myeloid leukemia

Current Topics in Microbiology and Immunology

Volumn 211, Issue , 1996, Pages 211-222

  Lopingco, M C ^a   Perkins, A S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

CONFERENCE PAPER; GENE REARRANGEMENT; LEUKEMOGENESIS; MOLECULAR BIOLOGY; MOUSE; MYELOID LEUKEMIA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN STRUCTURE; RETROVIRUS INFECTION;

MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0030048617     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-85232-9_21     Document Type: Conference Paper

References (63)

1. Bedigian H, Johnson D, Jenkins N, Copeland N, Evans R (1984) Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice. J Virol 51:586-594
2. Mucenski ML, Taylor BA, Jenkins NA, Copeland NG (1986) AKXD recombinant inbred strains: Models for studying the molecular genetic basis of murine lymphomas. Mol Cell Biol 6:4236-4243
3. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN (1988) Retroviral activation of a novel gene encoding a zinc finger protein in IL3-dependent myeloid leukemia cell lines. Cell 54:831-840
4. Buchberg AM, Bedigian HG, Jenkins NA, Copeland NG (1990) Evi-2, a common integration site, involved in murine myeloid leukemogenesis. Mol Cell Biol 10:4658-4666
5. Ben-David Y, Giddens EB, Bernstein A (1990) Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. pnas 87:1332-1336
6. Moreau-Gachelin F, Tavitian A, Tambourin P (1988) Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331:277-280
7. Aberdam D, Negreanu V, Sachs L, Blatt C (1991) The oncogenic potential of an activated hox-2.4 homeobox gene in mouse fibrolasts. Mol Cell Biol 11:554-557
8. Moskow J, Bullrich F, Huebner K, Buchberg A (1995) Personal communication.
9. Nakamura T, Copeland N (1995) personal communication
10. Mucenski ML, Taylor BA, Ihle JN, Hartley JW, Morse III HC, Jenkins NA, Copeland NG (1988) Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol 8:301-308
11. Bergeron D, Poliquin L, Houde J, Barbeau B, Rassart E (1992) Analysis of proviruses integrated in Fli-1 and Evi-1 regions in Cas-Br-E MuLV-induced non-T-, non-B-cell leukemias. Virology 191:661-669
12. Matsugi T, Morishita K, Ihle JN (1990) Identification, nuclear localization, and DNA-binding activity of the zinc finger protein encoded by the Evi-1 myeloid transforming gene. Mol Cell Biol 10:1259-1264
13. Bordereaux D, Fichelson S, Sola B, Tambourin PE, Gisselbrecht S (1987) Frequent involvement of the fim-3 region in Friend murine leukemia virus-induced mouse myeloblastic leukemias. J Virol 61:4043-4045
14. Bartholomew C, Morishita K, Askew D, Buchberg D, Jenkins NA, Copeland NG, Ihle JN (1989) Retroviral insertions in the CB-1/ Fim-3 common site of integration active expression of the Evi-1 gene. Oncogene 4:529-534
15. Bartholomew C, Ihle J (1991) Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter. Mol Cell Biol 11:1820-1828
16. Morishita K, Parganas E, Willman CL, Whittaker MH, Drabkin H, Oval J, Taetle R, Valentine MB, Ihle JN (1992) Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA 89:3937-3941
17. Oval J, Smedsrud M, Taetle R (1992) Expression and regulation of the Evi-1 gene in the human factor-dependent leukemia cell line, UCSD/AML1. Leukemia 6:446-451
18. Fichelson S, Dreyfus F, Berger R, Melle J, Bastard C, Miclea J, Gisselbrecht S (1992) Evi-1 expression in leukemic patients with rearrangements of the 3Q25-Q28 chromosomal region. Leukemia 6:93-99
19. Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton d, Pedersen-Bjergaard J, Parganas E, Ihle JN, Rowley JD (1994) Consistent intergenic splicing and production of multiple transcripts between AMLI at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Nat'l Acad Sci USA 91:4004-4008
20. Levy ER, Parganas E, Morishita K, Fichelson S, James L, Oscier D, Gisselbrecht S, Ihle JN, Buckle VJ (1994) DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome. Blood 83:1348-1354
21. Suzukawa K, Parganas E, Gajjar A, Abe T, Takahashi S, Tani K, Asano S, Asou H, Kamada N, Yokota J, Morishita K, Ihle JN (1994) Identification of a breakpoint cluster region 3′ of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). Blood 84:2681-2688
22. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H (1994) Generation of the AML1 - EVI-1 fusion gene in the t(3;21)(126;q22) causes blastic crisis in chronic myelocytic leukemia. The EMBO Journal 13:504-510
23. Morishita K, Parganas E, Bartholomew C, Sacchi N, Valentine MC, Raimondi SC, Le Beau MM, Ihle JN (1990) The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5) (q25;q34) translocations. Oncogene Research 5:221-231
24. Pintado T, Ferro M, San Roman C, Mayayo M, Larana J (1985) Clinical correlations of the 3q21;3q26 cytogenetic anomaly. A leukemic or myelodysplastic syndrome with preserved or increased platelet production and lack of response to cytotoxic drug therapy. Cancer 55:535-541
25. Bitter M, Neilly M, LeBeau M, Pearson M, Rowley J (1985) Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute non-lymphocytic leukemia. Blood 66:1362-1370
26. Bellomo M, Parlier V, Muhlematter D, Grob J, Beris P (1992) Three new cases of chromosome 3 rearrangements in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q213q26 syndrome. Cancer Genet Cytogenet 59:138
27. Schneider N, Bowman W, Frenkel E (1991) Translocation (3;21)(q26;q22) in secondary leukemia. Ann Genet 34:256-263
28. Rubin C, Larson R, Anastasi J, Winter J, Thangavelu M, Vardiman J, Rowley J, LeBeau M (1990) t(3;21)(q26;q22): A recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 76:2594-2598
29. Coyle T, Najfeld V (1988) Tranlocation (3;21) in Philadelphia chromosome-positive chromic myelogenous leukemia prior to the onset of blast crisis. Am J Hematol 27:56-59
30. Rubin C, Larson R, Bitter M, Carrino J, LeBeau M, Diaz M, Rowley J (1987) Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia. Blood 70:1338-1342
31. Kagoshima H, Shigesada K, Satake M, Ito Y, Miyoshi H, Ohki M, Pepling M, Gergen P (1993) The Runt domain identifies a new family of heteromeric trasncriptional regulators. Trends in Genetics 9:338-341
32. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y (1991) t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88:10431-10434
33. Nucifora G, Begy CR, Erickson P, Drabkin HA, Rowley JA (1993) The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. Proc. Natl. Acad. Sci. USA 90:7784-7788
34. Morishita K, Parganas E, Douglass EC, Ihle JN (1990) Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: Sequence of cDNAs and structure of alternatively spliced transcripts. Oncogene 5:963-971
35. Bordereaux D, Fichelson S, Tambourin P, Gisselbrecht S (1990) Alternative splicing of the Evi-1 zinc finger gene generates mRNAs which differ by the number of zinc finger motifs. Oncogene 5:925-927
36. Delwel R, Funabiki T, Kreider B, Morishita K, Ihle J (1993) Four of the seven zinc fingers of the Evi-1 myeloid transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA. Mol Cell Biol 13:4291-4300
37. Khanna-Gupta A, Savinelli T, Berliner N, Perkins A (1995) Retroviral insertional activation of the Evi1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line, 32Dcl3. Submitted
38. Dyck J, Maul G, Miller W, Chen J, Kakizuka A, Evans R (1994) A novel macromolecular structure is a target of the promyelocyte-receptor oncoprotein. Cell 76:333-343
39. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonesca M, Lamond A, Dejean A (1994) Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic cells. Cell 76:345-356
40. Jackson SP, Tjian R (1988) O-glycosylation of eukaryotic transcription factors: Implications for mechanism of transcriptional regulation. Cell 55:125-133
41. Perkins AS, Mercer JA, Jenkins NA, Copeland NG (1991) Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important role in mouse development. Development 111:479-487
42. Bartholomew C, Clark AM (1994) Induction of two alternatively spliced Evi-1 proto-oncogene transcripts by cAMP in kidney cells. Oncogene 9:939-942
43. Kreider B, Orkin S, Ihle J (1993) Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid transforming gene. Proc Natl Acad Sci, USA 90:6454-6458
44. Russell M, List A, Greenberg P, Woodward S, Glinsmann B, Parganas E, Ihle J, Taetle R (1994) Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood 84:1243-1248
45. Perkins AS, Fishel R, Jenkins NA, Copeland NG (1991) Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein. Mol Cell Biol 11:2665-2674
46. Funabiki T, Kreider BL, Ihle JN (1994) The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence GAAGATGAG. Oncogene 9:1575-1581
47. Pavletich N, Pabo C (1993) Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. Science 261:1701-1707
48. Pavletich N, Pabo C (1991) Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A,. Science 252:809-817
49. Klevit R (1991) Recognition of DNA by Cys2, His2 zinc fingers. Science 253:1367
50. Xu R, Horvath S, Klevit R (1991) ADR1a, a zinc finger peptide, exists in two folded conformations. Biochemistry 30:3365-3371
51. Kochoyan M, Havel TF, Nguyen DT, Dahl CE, Keutmann HT, Weiss MA (1991) Alternating zinc fingers in the human male associated protein ZFY: 2D NMR structure of an even finger and implications for "jumping-linker" DNA recognition. Biochemistry 30:3371-3386
52. Evans T, Reitman M, Felsenfeld G (1988) An erythroid-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc. Natl. Acad. Sci. USA 85:5976-5980
53. Wall L, deBoer E, Grosveld F (1988) The human β-globin gene 3′ enhancer contains multiple binding sites for an erythroid-specific protein. Genes and Dev 2:1089-1100
54. Mignotte V, Eleouet F, Raich N, Romeo P (1989) Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. Proc Natl Acad Sci, USA 86:6548-6551
55. Reitman M, Felsenfeld G (1988) Mutational analysis of the chicken beta-globin enhancer reveals two positive-acting domains. Proc Natl Acad Sci USA 85:6267-6271
56. Plumb M, Frampton J, Wainwright H, Walker M, Macleod K, Goodwin G, Harrison P (1989) GATAAG: a cis-control region binding an erythroid-specific nuclear factor with a role in globin and non-globin gene expression. Nucleic Acids Research 17:73-93
57. Martin D, Tsai S, Orkin S (1989) Increased gamma-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor. Nature 338:435-438
58. Glass C, Holloway J, Devary O, Rosenfeld M (1988) The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell 54:313-323
59. Ptashne M (1988) How eukaryotic transcriptional activators work. Nature 335:683-689
60. Sompayrac L, Danna K (1990) Method to identify genomic targets of DNA binding proteins. Proc. Natl. Acad. Sci. USA 87:3274-3278
61. McEntee K, Weinstock G, Lehman I (1980) recA protein catalyzed assimilation. Stimulation by Escherichia coli single-stranded DNA-binding protein. Proc. Natl. Acad. Sci. USA 77:857-861
62. Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V, Orkin S, Costantini F (1991) Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349:257-260
63. Tanaka T, Nishida J, Mitani K, Ogawa S, Yazaki Y, Hirai H (1994) Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain. J Biol Chem 269:24020-24026